<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: To assess the effect of Roux-en-Y gastric bypass (RYGB) at a tertiary referral Center of Excellence for bariatric surgery on the length and presence of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in morbidly <z:mp ids='MP_0001261'>obese</z:mp> patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">Esophageal reflux</z:e> of gastroduodenal contents (acid, bile) contributes to the development of BE and progression in the <z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0001261'>Obese</z:mp> patients have a high prevalence of <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> and might be at an increased risk of developing BE and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The effect of eliminating duodenogastroesophageal reflux on BE is not known </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We performed a retrospective review of <z:hpo ids='HP_0000001'>all</z:hpo> patients with pre-existing, biopsy-proven, long-segment (&gt;3 cm) BE undergoing RYGB at our institution </plain></SENT>
<SENT sid="5" pm="."><plain>Only patients with &gt;1 year of endoscopic, biopsy-controlled follow-up (mean 34 mo) were included </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Five patients (3 men and 2 women) were identified </plain></SENT>
<SENT sid="7" pm="."><plain>The mean +/- standard error of the mean preoperative length of BE was 6 +/- 2 cm; 2 patients had low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 1 indeterminate <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>At the postoperative follow-up (&gt;1 yr) examinations, the length of BE had decreased in 4 patients; the overall length was 2 +/- 1 cm; and only 1 patient had <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients experienced a decrease in the length of BE (n = 4), complete disappearance of BE (n = 2), or improvement in the degree of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 3) </plain></SENT>
<SENT sid="10" pm="."><plain>The body mass index had decreased from 43 +/- 4 kg/m(2) to 33 +/- 3 kg/m(2), and <z:hpo ids='HP_0000001'>all</z:hpo> experienced subjective improvement in reflux symptoms postoperatively </plain></SENT>
<SENT sid="11" pm="."><plain>RYGB resulted in complete or partial regression of BE in 4 of 5 patients and improvement in reflux symptoms in <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: Our results suggest that RYGB might be the procedure of choice in morbidly <z:mp ids='MP_0001261'>obese</z:mp> patients with BE requiring surgical treatment for <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> </plain></SENT>
</text></document>